This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Aarey Drugs & Pharmaceuticals Limited announced that it has received INR 106.581598 million in funding from Black Hawk Properties Private Limited, Rajan Dental Institute Private Limited, Marygold Health And Education Private Limited, Riddhi Trade Solutions Private Limited, Karan Monomer's Private Limited, Watco Chennai Real Estates Private Limited and other investors CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Aarey Drugs & Pharmaceuticals Limited Approves to Regularise the Appointment of Mrs. Bina Ghatalia as Non ­ Executive Director CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Aarey Drugs & Pharmaceuticals Limited Announces Directorate Changes CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Aarey Drugs Board to Consider Raising Funds Via Equity, Warrants MT
Aarey Drugs & Pharmaceuticals Limited announced that it expects to receive funding from Black Hawk Properties Private Limited, Rajan Dental Institute Private Limited, Marygold Health And Education Private Limited, Riddhi Trade Solutions Private Limited, Karan Monomer's Private Limited, Watco Chennai Real Estates Private Limited CI
Worth Investment & Trading Company Limited announced that it expects to receive INR 201.15578 million in funding from a group of investors CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Aarey Drugs & Pharmaceuticals' Board Allot 2 Million Equity Shares MT
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Aarey Drugs & Pharmaceuticals Limited announced that it expects to receive INR 80.74 million in funding from Nimit Impex Pvt Ltd, Suraj Tradelinks Private Limited, and other investors CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Aarey Drugs & Pharmaceuticals Limited Approves the Appointment of Mira M Ghatalia as an Chief Financial Officer CI
Aarey Drugs & Pharmaceuticals : CFO Tenders Resignation MT
Aarey Drugs & Pharmaceuticals Limited Announces Resignation of Rajesh Pranlal Ghatalia, CFO CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Chart Aarey Drugs & Pharmaceuticals Limited
More charts
Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxaphylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The Company's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Chlorinated Solvents, Industrial Intermediates, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.
More about the company